Enovix
ENVX
2.55
-0.15
-5.56%
Enovix
US · ENVX
#3673 by market cap
2.55
-0.15
-5.56%
Live - 5344 symbols - heartbeat 219s ago
· 2026-10-08 09:19
Pre-market
2.51
-1.57%
After-hours
2.58
+1.18%
Overnight
2.54
-0.39%
- Market cap
- 559.59M
- P/E (TTM)i
- -3.23
- P/Bi
- 2.66
- EPSi
- -0.75
- Div yieldi
- 0.00%
- 52W posi
- 1%
Reader sentiment
Are you bullish or bearish on ENVX?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is -0.98, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 6 years
Latest year +37.91% YoY
Margins
- Gross margin
- 19.19%
- Operating margin
- -557.03%
- Net margin
- -492.57%
Key ratios & quality
- Enterprise valuei
- 576.69M
- Altman Z-Scorei
- -0.98
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2020 | 2022 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 6.20M | 7.64M | 23.07M | 31.82M |
| Gross profit | -3.38M | -1.97M | -17.04M | -55.42M | -2.05M | 6.11M |
| Selling & admin expenses | 5.71M | 29.71M | 51.97M | 79.01M | 74.31M | 73.03M |
| Research & development | 14.44M | 37.85M | 58.05M | 88.39M | 124.51M | 110.33M |
| Operating profit | -23.53M | -69.52M | -127.06M | -222.82M | -200.86M | -177.25M |
| Pretax profit | -39.65M | -125.87M | -51.62M | -214.77M | -223.93M | -157.92M |
| Tax | -- | 0 | 0 | -633.00K | -1.39M | -1.31M |
| Net profit | -39.65M | -125.87M | -51.62M | -214.13M | -222.53M | -156.61M |
| Basic EPS | 0 | -1 | 0 | -1 | -1 | -1 |
| Diluted EPS | -0.27 | -1.07 | -0.82 | -1.30 | -1.19 | -0.75 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 5.10M | 7.47M | 7.99M | 11.27M | 7.60M | 9.02M |
| Gross profit | 261.00K | 1.94M | 1.40M | 2.50M | 1.55M | 1.30M |
| Selling & admin expenses | 16.89M | 17.53M | 20.19M | 18.42M | 18.92M | 20.15M |
| Research & development | 25.93M | 28.15M | 28.18M | 28.07M | 26.53M | 24.44M |
| Operating profit | -42.56M | -43.73M | -46.97M | -43.99M | -43.90M | -43.30M |
| Pretax profit | -23.69M | -45.13M | -54.19M | -34.91M | -38.39M | -43.52M |
| Tax | -162.00K | -861.00K | -422.00K | 133.00K | -129.00K | -441.00K |
| Net profit | -23.53M | -44.27M | -53.77M | -35.04M | -38.26M | -43.08M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.12 | -0.22 | -0.27 | -0.16 | -0.18 | -0.20 |
Balance sheet
| Line item | 2020 | 2022 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total current assets | 33.04M | 398.12M | 329.65M | 323.18M | 295.01M | 542.21M |
| Cash & ST investments | 29.14M | 385.29M | 322.85M | 306.82M | 272.87M | 512.04M |
| Inventory | -- | 0 | 634.00K | 8.74M | 7.66M | 13.62M |
| Total assets | 64.96M | 482.57M | 440.59M | 564.30M | 527.17M | 878.98M |
| Total current liabilities | 10.87M | 20.64M | 23.03M | 61.02M | 53.70M | 65.02M |
| Short-term debt | -- | -- | -- | 5.92M | 9.45M | 9.87M |
| Long-term debt | -- | -- | -- | 169.10M | 169.82M | 519.27M |
| Total liabilities | 28,748,000.00 | 156,448,000.00 | 84,159,000.00 | 303,201,000.00 | 277,766,000.00 | 604,964,000.00 |
| Total equity | 36.22M | 326.12M | 356.43M | 261.10M | 249.40M | 274.01M |
| Retained earnings | -207.28M | -333.15M | -384.77M | -598.85M | -821.09M | -977.83M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 270.17M | 228.34M | 588.63M | 542.21M | 558.50M | 505.74M |
| Cash & ST investments | 248.16M | 203.41M | 558.82M | 512.04M | 528.74M | 475.78M |
| Inventory | 10.48M | 13.39M | 15.22M | 13.62M | 16.45M | 17.52M |
| Total assets | 499.05M | 469.11M | 913.71M | 878.98M | 833.89M | 799.62M |
| Total current liabilities | 57.79M | 52.28M | 60.57M | 65.02M | 50.89M | 52.11M |
| Short-term debt | 10.37M | 10.41M | 10.15M | 9.87M | 9.44M | 10.59M |
| Long-term debt | 169.19M | 169.44M | 518.35M | 519.27M | 520.16M | 520.99M |
| Total liabilities | 261,261,000.00 | 262,460,000.00 | 616,606,000.00 | 604,964,000.00 | 591,163,000.00 | 587,630,000.00 |
| Total equity | 237.78M | 206.65M | 297.10M | 274.01M | 242.73M | 211.99M |
| Retained earnings | -844.60M | -889.12M | -942.84M | -977.83M | -1.02B | -1.06B |
Cash flow
| Line item | 2020 | 2022 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -20.05M | -51.31M | -82.74M | -104.64M | -108.63M | -95.29M |
| Depreciation & amortization | 579.00K | 1.52M | 7.97M | 34.01M | 44.96M | 35.11M |
| Free cash flow | -47.00M | -94.89M | -118.95M | -166.43M | -184.82M | -113.51M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | -27.00K | -10.00K | -26.00K | 107.19M | -58.39M |
| Ending cash balance | 29.22M | 385.42M | 322.98M | 235.12M | 274.69M | 107.98M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | -16.91M | -25.86M | -25.53M | -27.00M | -33.07M | -21.78M |
| Depreciation & amortization | 8.45M | 8.83M | 9.40M | 8.44M | 9.37M | 10.04M |
| Free cash flow | -23.18M | -33.83M | -28.50M | -28.01M | -36.29M | -31.41M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | 0 | -- | -- |
| Ending cash balance | 191.69M | 138.05M | 337.52M | 107.98M | 90.63M | 35.59M |
Returns & efficiency
| Line item | 2020 | 2022 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| ROE %i | -109.48 | -69.48 | -15.13 | -69.66 | -88.04 | -60.52 |
| ROA %i | -61.03 | -45.98 | -11.18 | -42.61 | -40.72 | -22.29 |
| ROIC %i | -109.19 | -67.68 | -16.25 | -54.59 | -51.29 | -23.70 |
| 5-year avg ROE %i | -- | -- | -- | -- | -70.36 | -60.57 |
| EBIT margin %i | -- | -- | -2,048.66 | -2,751.30 | -941.05 | -428.40 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 3.04 | 19.29 | 14.31 | 5.30 | 5.49 | 8.34 |
| Quick ratioi | 2.68 | 18.67 | 14.03 | 5.07 | 5.17 | 8.01 |
| Debt / assetsi | 0.00 | 1.88 | 1.87 | 33.78 | 36.53 | 61.48 |
| LT debt / equityi | -- | 2.78 | 2.31 | 71.55 | 74.21 | 195.61 |
| Interest coveragei | -369.56 | -672.12 | -- | -47.20 | -31.99 | -6.31 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | 72.48 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | -85.86 | -68.46 | -68.95 | -60.52 | -72.08 | -82.20 |
| ROA %i | -39.56 | -26.73 | -23.38 | -22.29 | -25.73 | -26.80 |
| ROIC %i | -48.04 | -34.42 | -25.46 | -23.70 | -26.65 | -27.54 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -847.71 | -446.26 | -470.41 | -428.40 | -424.57 | -388.25 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 4.68 | 4.37 | 9.72 | 8.34 | 10.97 | 9.71 |
| Quick ratioi | 4.37 | 3.99 | 9.34 | 8.01 | 10.47 | 9.19 |
| Debt / assetsi | 38.51 | 40.93 | 59.09 | 61.48 | 64.82 | 67.22 |
| LT debt / equityi | 77.32 | 89.14 | 180.03 | 195.61 | 220.66 | 250.96 |
| Interest coveragei | -28.36 | -17.31 | -8.42 | -6.31 | -5.42 | -4.39 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Product revenue100.00%
Quote time 2026-10-08 09:19:39 · For reference only, not investment advice and not tailored to your situation.